Evidence Details for SLC39A10
 Basic Information Top
 Basic Information Top
| Gene Symbol: | SLC39A10 ( DKFZp781L10106,LZT-Hs2,MGC126565,MGC138428 ) | 
|---|---|
| Gene Full Name: | solute carrier family 39 (zinc transporter), member 10 | 
| Band: | 2q32.3 | 
| Quick Links | Entrez ID:57181; OMIM: 608733; Uniprot ID:S39AA_HUMAN; ENSEMBL ID: ENSG00000196950; HGNC ID: 20861 | 
| Relate to Another Database: | SFARIGene; denovo-db | 
 Sequences Top
 Sequences Top
>SLC39A10|57181|nucleotide
ATGAAGGTACATATGCACACAAAATTTTGCCTCATTTGTTTGCTGACATTTATTTTTCATCATTGCAACCATTGCCATGAAGAACATGACCATGGCCCTGAAGCG
CTTCACAGACAGCATCGTGGAATGACAGAATTGGAGCCAAGCAAATTTTCAAAGCAAGCTGCTGAAAATGAAAAAAAATACTATATTGAAAAACTTTTTGAGCGT
TATGGTGAAAATGGAAGATTATCCTTTTTTGGTTTGGAGAAACTTTTAACAAACTTGGGCCTTGGAGAGAGAAAAGTAGTTGAGATTAATCATGAGGATCTTGGC
CACGATCATGTTTCTCATTTAGATATTTTGGCAGTTCAAGAGGGAAAGCATTTTCACTCACATAACCACCAGCATTCCCATAATCATTTAAATTCAGAAAATCAA
ACTGTGACCAGTGTATCCACAAAAAGAAACCATAAATGTGATCCAGAGAAAGAGACAGTTGAAGTGTCTGTAAAATCTGATGATAAACATATGCATGACCATAAT
CACCGCCTACGTCATCACCATCGTTTGCATCATCATCTTGATCATAACAACACTCACCATTTTCATAATGATTCCATTACTCCCAGTGAGCGTGGGGAGCCTAGC
AATGAACCTTCAACAGAGACCAATAAAACCCAGGAACAATCTGATGTTAAACTACCGAAAGGAAAGAGGAAGAAAAAAGGGAGGAAAAGTAATGAAAATTCTGAG
GTTATTACACCAGGTTTTCCCCCTAACCATGATCAGGGTGAACAGTATGAGCATAATCGGGTCCACAAACCTGATCGTGTACATAACCCAGGTCATTCTCATGTA
CATCTTCCAGAACGTAATGGTCATGATCCTGGTCGTGGACACCAAGATCTTGATCCTGATAATGAAGGTGAACTTCGACATACTAGAAAGAGAGAAGCACCACAT
GTTAAAAATAATGCAATAATTTCTTTGAGAAAAGATCTAAATGAAGATGACCATCATCATGAATGTTTGAACGTCACTCAGTTATTAAAATACTATGGTCATGGT
GCCAACTCTCCCATCTCAACTGATTTATTTACATACCTTTGCCCTGCATTGTTATATCAAATCGACAGCAGACTTTGTATTGAGCATTTTGACAAACTTTTAGTT
Show »
ATGAAGGTACATATGCACACAAAATTTTGCCTCATTTGTTTGCTGACATTTATTTTTCATCATTGCAACCATTGCCATGAAGAACATGACCATGGCCCTGAAGCG
CTTCACAGACAGCATCGTGGAATGACAGAATTGGAGCCAAGCAAATTTTCAAAGCAAGCTGCTGAAAATGAAAAAAAATACTATATTGAAAAACTTTTTGAGCGT
TATGGTGAAAATGGAAGATTATCCTTTTTTGGTTTGGAGAAACTTTTAACAAACTTGGGCCTTGGAGAGAGAAAAGTAGTTGAGATTAATCATGAGGATCTTGGC
CACGATCATGTTTCTCATTTAGATATTTTGGCAGTTCAAGAGGGAAAGCATTTTCACTCACATAACCACCAGCATTCCCATAATCATTTAAATTCAGAAAATCAA
ACTGTGACCAGTGTATCCACAAAAAGAAACCATAAATGTGATCCAGAGAAAGAGACAGTTGAAGTGTCTGTAAAATCTGATGATAAACATATGCATGACCATAAT
CACCGCCTACGTCATCACCATCGTTTGCATCATCATCTTGATCATAACAACACTCACCATTTTCATAATGATTCCATTACTCCCAGTGAGCGTGGGGAGCCTAGC
AATGAACCTTCAACAGAGACCAATAAAACCCAGGAACAATCTGATGTTAAACTACCGAAAGGAAAGAGGAAGAAAAAAGGGAGGAAAAGTAATGAAAATTCTGAG
GTTATTACACCAGGTTTTCCCCCTAACCATGATCAGGGTGAACAGTATGAGCATAATCGGGTCCACAAACCTGATCGTGTACATAACCCAGGTCATTCTCATGTA
CATCTTCCAGAACGTAATGGTCATGATCCTGGTCGTGGACACCAAGATCTTGATCCTGATAATGAAGGTGAACTTCGACATACTAGAAAGAGAGAAGCACCACAT
GTTAAAAATAATGCAATAATTTCTTTGAGAAAAGATCTAAATGAAGATGACCATCATCATGAATGTTTGAACGTCACTCAGTTATTAAAATACTATGGTCATGGT
GCCAACTCTCCCATCTCAACTGATTTATTTACATACCTTTGCCCTGCATTGTTATATCAAATCGACAGCAGACTTTGTATTGAGCATTTTGACAAACTTTTAGTT
Show »
>SLC39A10|57181|protein
MKVHMHTKFCLICLLTFIFHHCNHCHEEHDHGPEALHRQHRGMTELEPSKFSKQAAENEKKYYIEKLFERYGENGRLSFFGLEKLLTNLGLGERKVVEINHEDLG
HDHVSHLDILAVQEGKHFHSHNHQHSHNHLNSENQTVTSVSTKRNHKCDPEKETVEVSVKSDDKHMHDHNHRLRHHHRLHHHLDHNNTHHFHNDSITPSERGEPS
NEPSTETNKTQEQSDVKLPKGKRKKKGRKSNENSEVITPGFPPNHDQGEQYEHNRVHKPDRVHNPGHSHVHLPERNGHDPGRGHQDLDPDNEGELRHTRKREAPH
VKNNAIISLRKDLNEDDHHHECLNVTQLLKYYGHGANSPISTDLFTYLCPALLYQIDSRLCIEHFDKLLVEDINKDKNLVPEDEANIGASAWICGIISITVISLL
SLLGVILVPIINQGCFKFLLTFLVALAVGTMSGDALLHLLPHSQGGHDHSHQHAHGHGHSHGHESNKFLEEYDAVLKGLVALGGIYLLFIIEHCIRMFKHYKQQR
Show »
MKVHMHTKFCLICLLTFIFHHCNHCHEEHDHGPEALHRQHRGMTELEPSKFSKQAAENEKKYYIEKLFERYGENGRLSFFGLEKLLTNLGLGERKVVEINHEDLG
HDHVSHLDILAVQEGKHFHSHNHQHSHNHLNSENQTVTSVSTKRNHKCDPEKETVEVSVKSDDKHMHDHNHRLRHHHRLHHHLDHNNTHHFHNDSITPSERGEPS
NEPSTETNKTQEQSDVKLPKGKRKKKGRKSNENSEVITPGFPPNHDQGEQYEHNRVHKPDRVHNPGHSHVHLPERNGHDPGRGHQDLDPDNEGELRHTRKREAPH
VKNNAIISLRKDLNEDDHHHECLNVTQLLKYYGHGANSPISTDLFTYLCPALLYQIDSRLCIEHFDKLLVEDINKDKNLVPEDEANIGASAWICGIISITVISLL
SLLGVILVPIINQGCFKFLLTFLVALAVGTMSGDALLHLLPHSQGGHDHSHQHAHGHGHSHGHESNKFLEEYDAVLKGLVALGGIYLLFIIEHCIRMFKHYKQQR
Show »
 Evidence summary Top
 Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
| Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| Score (No. of Studies) | No | 0 (1) | 1 (1) | 0 (0) | 0 (0) | 2 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (4) | 
 Syndromic Autism Gene Top
Syndromic Autism Gene Top
 Genome-Wide Association Studies (By Ethnic Group) Top
Genome-Wide Association Studies (By Ethnic Group) Top
 Family Based Association Studies: 1
| Reference | Stage | Platform | #Families | Affecteds | Result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) | ADI-R | ADOS | Diagnosis | Age (range) | IQ (range) | ||||||
| CAUCASIAN | |||||||||||
| Hussman, 2011_1 | Discovery | Illumina Infinium Human 1 M beadship | 597 | - (-) |  |  | ASD | - - | - - | ||
 Case Control Based Association Studies: 0
| Reference | Stage | Platform | ASD Cases | Normal Controls | Result | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) | ADI-R | ADOS | Diagnosis | Age (range) | IQ | #Subjects (% Women) | Age (range) | |||||
| No Evidence. | ||||||||||||
 CNV Studies Top
CNV Studies Top
| Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
| Gallagher, 2003 | - | Chromosomal analysis of G-band |  |  | autism | - | - | - | - | 1 | - | 1 | 
 Linkage Studies Top
Linkage Studies Top
 Low Scale Association Studies (by Ethnic Group) Top
Low Scale Association Studies (by Ethnic Group) Top
 Large Scale Expression Studies Top
Large Scale Expression Studies Top
 Microarray Studies: 2
| Reference | Source | Tissue | #Subjects (% Women) | ADI-R | ADOS | Endo- pheno | Diagnosis | Normal Controls (% Women) | Fold Change | Up/ Down | P/Q value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voineagu, 2011_1 | Unknown | 16 frontal cortex(BA9) and 13 temporal cortex(BA41 | 16 (25.00%) |  |  | - | autism | 16 (6.25%) | 0.736522 | Down | 0.183255 | |
| 
 | ||||||||||||
| Voineagu, 2011_2 | Unknown | frontal, BA44/45 | 10 (0.00%) |  |  | - | autism | 6 (0.00%) | 0.800381 | Down | 0.0742865 | |
| 
 | ||||||||||||
 Proteomics Studies:0
| Reference | Source | Tissue | Platform | #Subjects (% Women) | ADI-R | ADOS | Diagnosis | Normal Controls(% Women) | |
|---|---|---|---|---|---|---|---|---|---|
| No Evidence. | |||||||||
 NGS de novo Mutation Studies Top
NGS de novo Mutation Studies Top
 NGS Mosaic SNV Studies Top
NGS Mosaic SNV Studies Top
 NGS Other Studies Top
NGS Other Studies Top
 Low Scale Gene Studies Top
 Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.

